These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 9009975)
1. Cardiovascular events and correlates in the Veterans Affairs Diabetes Feasibility Trial. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes. Abraira C; Colwell J; Nuttall F; Sawin CT; Henderson W; Comstock JP; Emanuele NV; Levin SR; Pacold I; Lee HS Arch Intern Med; 1997 Jan; 157(2):181-8. PubMed ID: 9009975 [TBL] [Abstract][Full Text] [Related]
2. Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes. Abraira C; Colwell JA; Nuttall FQ; Sawin CT; Nagel NJ; Comstock JP; Emanuele NV; Levin SR; Henderson W; Lee HS Diabetes Care; 1995 Aug; 18(8):1113-23. PubMed ID: 7587846 [TBL] [Abstract][Full Text] [Related]
3. The feasibility of intensive insulin management in non-insulin-dependent diabetes mellitus. Implications of the Veterans Affairs Cooperative Study on Glycemic Control and Complications in NIDDM. Colwell JA Ann Intern Med; 1996 Jan; 124(1 Pt 2):131-5. PubMed ID: 8554205 [TBL] [Abstract][Full Text] [Related]
4. Response to intensive therapy steps and to glipizide dose in combination with insulin in type 2 diabetes. VA feasibility study on glycemic control and complications (VA CSDM). Abraira C; Henderson WG; Colwell JA; Nuttall FQ; Comstock JP; Emanuele NV; Levin SR; Sawin CT; Silbert CK Diabetes Care; 1998 Apr; 21(4):574-9. PubMed ID: 9571345 [TBL] [Abstract][Full Text] [Related]
5. Evaluations of retinopathy in the VA Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM). A feasibility study. Emanuele N; Klein R; Abraira C; Colwell J; Comstock J; Henderson WG; Levin S; Nuttall F; Sawin C; Silbert C; Lee HS; Johnson-Nagel N Diabetes Care; 1996 Dec; 19(12):1375-81. PubMed ID: 8941467 [TBL] [Abstract][Full Text] [Related]
6. The effects of intensive glycemic control on neuropathy in the VA cooperative study on type II diabetes mellitus (VA CSDM). Azad N; Emanuele NV; Abraira C; Henderson WG; Colwell J; Levin SR; Nuttall FQ; Comstock JP; Sawin CT; Silbert C; Rubino FA J Diabetes Complications; 1999; 13(5-6):307-13. PubMed ID: 10765007 [TBL] [Abstract][Full Text] [Related]
7. Design of the cooperative study on glycemic control and complications in diabetes mellitus type 2: Veterans Affairs Diabetes Trial. Abraira C; Duckworth W; McCarren M; Emanuele N; Arca D; Reda D; Henderson W; J Diabetes Complications; 2003; 17(6):314-22. PubMed ID: 14583175 [TBL] [Abstract][Full Text] [Related]
8. Effect of intensive glycemic control on fibrinogen, lipids, and lipoproteins: Veterans Affairs Cooperative Study in Type II Diabetes Mellitus. Emanuele N; Azad N; Abraira C; Henderson W; Colwell J; Levin S; Nuttall F; Comstock J; Sawin C; Silbert C; Marcovina S; Lee HS Arch Intern Med; 1998 Dec 7-21; 158(22):2485-90. PubMed ID: 9855387 [TBL] [Abstract][Full Text] [Related]
9. Two years of intensive glycemic control and left ventricular function in the Veterans Affairs Cooperative Study in Type 2 Diabetes Mellitus (VA CSDM). Pitale SU; Abraira C; Emanuele NV; McCarren M; Henderson WG; Pacold I; Bushnell D; Colwell JA; Nuttall FQ; Levin SR; Sawin CT; Comstock JP; Silbert CK Diabetes Care; 2000 Sep; 23(9):1316-20. PubMed ID: 10977025 [TBL] [Abstract][Full Text] [Related]
10. Intensive insulin therapy in patients with type 2 diabetes: implications of the Veterans affairs (VA CSDM) feasibility trial. Abraira C; McGuire DK Am Heart J; 1999 Nov; 138(5 Pt 1):S360-5. PubMed ID: 10539798 [No Abstract] [Full Text] [Related]
11. Glucose control and vascular complications in veterans with type 2 diabetes. Duckworth W; Abraira C; Moritz T; Reda D; Emanuele N; Reaven PD; Zieve FJ; Marks J; Davis SN; Hayward R; Warren SR; Goldman S; McCarren M; Vitek ME; Henderson WG; Huang GD; N Engl J Med; 2009 Jan; 360(2):129-39. PubMed ID: 19092145 [TBL] [Abstract][Full Text] [Related]
12. Effects of Severe Hypoglycemia on Cardiovascular Outcomes and Death in the Veterans Affairs Diabetes Trial. Davis SN; Duckworth W; Emanuele N; Hayward RA; Wiitala WL; Thottapurathu L; Reda DJ; Reaven PD; Diabetes Care; 2019 Jan; 42(1):157-163. PubMed ID: 30455335 [TBL] [Abstract][Full Text] [Related]
13. Characterization of cardiovascular outcomes in a type 2 diabetes glucose supply and insulin demand model. Monte SV; Schentag JJ; Adelman MH; Paladino JA J Diabetes Sci Technol; 2010 Mar; 4(2):382-90. PubMed ID: 20307400 [TBL] [Abstract][Full Text] [Related]
14. Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes. Hayward RA; Reaven PD; Wiitala WL; Bahn GD; Reda DJ; Ge L; McCarren M; Duckworth WC; Emanuele NV; N Engl J Med; 2015 Jun; 372(23):2197-206. PubMed ID: 26039600 [TBL] [Abstract][Full Text] [Related]
15. Ethnic differences in the glycemic response to exogenous insulin treatment in the Veterans Affairs Cooperative Study in Type 2 Diabetes Mellitus (VA CSDM). Agrawal L; Emanuele NV; Abraira C; Henderson WG; Levin SR; Sawin CT; Silbert CK; Nuttall FQ; Comstock JP; Colwell JA Diabetes Care; 1998 Apr; 21(4):510-5. PubMed ID: 9571333 [TBL] [Abstract][Full Text] [Related]
16. Randomized, open-label, parallel-group evaluations of basal-bolus therapy versus insulin lispro premixed therapy in patients with type 2 diabetes mellitus failing to achieve control with starter insulin treatment and continuing oral antihyperglycemic drugs: a noninferiority intensification substudy of the DURABLE trial. Miser WF; Arakaki R; Jiang H; Scism-Bacon J; Anderson PW; Fahrbach JL Clin Ther; 2010 May; 32(5):896-908. PubMed ID: 20685497 [TBL] [Abstract][Full Text] [Related]
17. Effect of intensive glycemic control on microalbuminuria in type 2 diabetes. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type 2 Diabetes Feasibility Trial Investigators. Levin SR; Coburn JW; Abraira C; Henderson WG; Colwell JA; Emanuele NV; Nuttall FQ; Sawin CT; Comstock JP; Silbert CK Diabetes Care; 2000 Oct; 23(10):1478-85. PubMed ID: 11023140 [TBL] [Abstract][Full Text] [Related]
18. Intensive glucose-lowering therapy reduces cardiovascular disease events in veterans affairs diabetes trial participants with lower calcified coronary atherosclerosis. Reaven PD; Moritz TE; Schwenke DC; Anderson RJ; Criqui M; Detrano R; Emanuele N; Kayshap M; Marks J; Mudaliar S; Harsha Rao R; Shah JH; Goldman S; Reda DJ; McCarren M; Abraira C; Duckworth W; Diabetes; 2009 Nov; 58(11):2642-8. PubMed ID: 19651816 [TBL] [Abstract][Full Text] [Related]
19. Health-related quality of life in the VA Feasibility Study on glycemic control and complications in type 2 diabetes mellitus. Pitale S; Kernan-Schroeder D; Emanuele N; Sawin C; Sacks J; Abraira C; J Diabetes Complications; 2005; 19(4):207-11. PubMed ID: 15993354 [TBL] [Abstract][Full Text] [Related]
20. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison. Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]